1. Home
  2. ABCL vs AXGN Comparison

ABCL vs AXGN Comparison

Compare ABCL & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • AXGN
  • Stock Information
  • Founded
  • ABCL 2012
  • AXGN N/A
  • Country
  • ABCL Canada
  • AXGN United States
  • Employees
  • ABCL N/A
  • AXGN N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ABCL Health Care
  • AXGN Health Care
  • Exchange
  • ABCL Nasdaq
  • AXGN Nasdaq
  • Market Cap
  • ABCL 1.1B
  • AXGN 1.2B
  • IPO Year
  • ABCL 2020
  • AXGN N/A
  • Fundamental
  • Price
  • ABCL $3.61
  • AXGN $28.63
  • Analyst Decision
  • ABCL Buy
  • AXGN Strong Buy
  • Analyst Count
  • ABCL 5
  • AXGN 7
  • Target Price
  • ABCL $7.75
  • AXGN $27.71
  • AVG Volume (30 Days)
  • ABCL 5.2M
  • AXGN 900.8K
  • Earning Date
  • ABCL 11-06-2025
  • AXGN 10-29-2025
  • Dividend Yield
  • ABCL N/A
  • AXGN N/A
  • EPS Growth
  • ABCL N/A
  • AXGN N/A
  • EPS
  • ABCL N/A
  • AXGN N/A
  • Revenue
  • ABCL $35,325,000.00
  • AXGN $214,709,000.00
  • Revenue This Year
  • ABCL $16.99
  • AXGN $21.57
  • Revenue Next Year
  • ABCL $62.91
  • AXGN $15.79
  • P/E Ratio
  • ABCL N/A
  • AXGN N/A
  • Revenue Growth
  • ABCL 7.17
  • AXGN 18.72
  • 52 Week Low
  • ABCL $1.89
  • AXGN $9.22
  • 52 Week High
  • ABCL $6.52
  • AXGN $28.92
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 33.35
  • AXGN 83.29
  • Support Level
  • ABCL $3.33
  • AXGN $23.00
  • Resistance Level
  • ABCL $3.83
  • AXGN $28.92
  • Average True Range (ATR)
  • ABCL 0.27
  • AXGN 1.17
  • MACD
  • ABCL -0.01
  • AXGN 0.30
  • Stochastic Oscillator
  • ABCL 34.30
  • AXGN 94.26

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: